Dr. Christine M. Cole, MD

Dr. Cole practices at Center for Dermatology Care in Manitowoc, Wisconsin.

Dr. Cole's NPI, 1770796708, was assigned on May 7, 2007. Dr. Cole graduated from Loma Linda University School Of Medicine in 2007. Dr. Cole holds California license A119802.

Dr. Cole's primary practice is Center for Dermatology Care, at 801 York St, Manitowoc, WI 54220 in Manitowoc County. The practice phone is (805) 497-1694.

Dr. Cole's primary practice is Center for Dermatology Care in Manitowoc, Wisconsin. The medical group on file is Forefront Dermatology. Dmand AI also links Dr. Cole to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cole practices. Vendor and product names are available with a free account.

Dermatology is Dr. Cole's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Cole is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Cole's licenses on file in 3 states: California, Pennsylvania and Arizona.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Cole treats.

CMS data shows 11,584 Medicare services from Dr. Cole across 27 procedure codes in 2024, for 1,781 Medicare patients. Medicare paid $486,236 for them. Every service was in an office.

CMS counts 1,781 Medicare patients who saw Dr. Cole in 2024. The largest group is 65 to 74, with 778 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cole's median patient age at 65, with 58% women.

In 2024, Dr. Cole wrote 606 Medicare Part D claims for 256 patients. 94% of them were for generic drugs. CMS names the drug for 506 of them, across 13 drugs with 11 or more claims each, at $75,319 in total drug cost. In 2023, CMS named 409 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Cole for performance year 2024, reported as part of a group. Dr. Cole accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,188 procedures of skin biopsy by Dr. Cole, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Cole, published from 2013 to 2016. The most frequent topics are Skin Neoplasms. Dr. Cole's most frequent co-authors are Aaron R. Mangold, MD, David J. Dicaudo, MD and Susan D. Laman, MD.

CMS Open Payments shows 107 general payments to Dr. Cole from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $382.

Dr. Cole graduated from Loma Linda University School Of Medicine in 2007.

Dr. Cole is in network with 15 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.